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ABSTRACT 
Aims: To estimate the proportions of farms on which broilers, turkeys and pigs were shedding 
fluoroquinolone (FQ)-resistant E. coli or Campylobacter spp. near to slaughter. 
 Methods and Results: Freshly-voided faeces were collected on 89 poultry and 108 pig farms and 
cultured with media containing 1.0 mg l-1 ciprofloxacin. Studies demonstrated the specificity of this 
sensitive method, and both poultry and pig sampling yielded FQ-resistant E. coli on 60% of farms. 
FQ-resistant Campylobacter spp. were found on around 22% of poultry and 75% of pig farms. The 
majority of resistant isolates of Campylobacter (89%) and E. coli (96%) tested had minimum 
inhibitory concentrations for ciprofloxacin of ≥8 mg l-1. The proportion of resistant E. coli and 
Campylobacter organisms within samples varied widely. 
Conclusions: FQ resistance is commonly present among two enteric bacterial genera prevalent on 
pig and poultry farms, although the low proportion of resistant organisms in many cases requires a 
sensitive detection technique. 
Significance and Impact of Study: FQ-resistant bacteria with zoonotic potential appear to be 
present on a high proportion of UK pig and poultry farms. The risk this poses to consumers relative 
to other causes of FQ-resistant human infections remains to be clarified. 
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INTRODUCTION 
Fluoroquinolones (FQ) are a class of antimicrobial drugs effective against a wide range of human 
diseases and are used in both treatment and prophylaxis of bacterial infections. FQ have been 
particularly important in the treatment of serious food-borne infections which may often be resistant 
to other antimicrobials (Hopkins et al. 2005). FQ are also used in veterinary medicine and there is 
concern that their use in food animals may lead to resistance in certain bacteria, resulting in difficulty 
in treating food-borne infections in man (Aarestrup and Wegener 1999; van den Boogard and 
Stobberingh 2000; Bager and Helmuth 2001;Webber and Piddock 2001). 
Quinolone and FQ antimicrobials were introduced, initially on a trial basis, in poultry and as 
quasi-legal imports from the Netherlands for veal production, followed by official licensing for 
poultry in the UK in 1993 (Piddock 1995). Indications for use in poultry extend to respiratory and 
enteric diseases and septicaemia (Hopkins et al. 2005). A rapid rise in resistance to the quinolone 
nalidixic acid was observed in Salmonella from turkeys following the introduction of FQ treatment 
(Davies et al. 1999). Resistance to FQ in human isolates of Campylobacter has been reported world-
wide since the early 1990s (Endtz et al. 1991; Piddock 1995; Engberg et al. 2004), with increasing 
resistance in Escherichia coli documented more recently (Acar and Goldstein 1997; Threlfall et al. 
1998). FQ resistance in human, veterinary and food isolates of Campylobacter and E. coli is reported 
commonly in surveillance (Anon 2005a, b; Bengtsson et al. 2005) and research (Giraud et al. 2001; 
Gupta et al. 2004; Ge et al. 2005) literature. 
Thermophilic Campylobacter spp. are common commensal organisms of poultry and pigs, with 
zoonotic potential (Padungton and Kaneene 2003). Rapid selection of resistance has been observed 
following standard FQ therapy of Campylobacter–colonised broiler chickens under both natural 
(Griggs et al. 2005) and experimental (McDermott et al. 2002; van Boven et al. 2003) conditions, 
and in treated pigs (Delsol et al. 2004). Prior to veterinary licensing of FQ, levels of resistance 
amongst human and poultry Campylobacter were low (Endtz et al. 1991; Gaunt and Piddock 1996), 
and it has been proposed (Endtz et al. 1991) that the veterinary use of FQ has led to the selection of 
FQ-resistant Campylobacter, particularly in poultry, which then enter the food-chain and create a 
risk to public health. After the licensing of veterinary FQ, there was a substantial rise in FQ 
resistance among both veterinary and human Campylobacter isolates (Endtz et al. 1991; Aarestrup 
and Wegener 1999; Gupta et al. 2004) although in several countries an increasing trend was present 
before veterinary use, which often was associated with recent foreign travel (Rautelin et al. 1991; 
Smith et al. 1999). 
The contribution of poultry meat to the transmission of resistant Campylobacter to humans has 
been vigorously debated. Consumption of meat products, particularly out of the home, is associated 
with an increased risk of infection with an FQ-resistant Campylobacter sp. (Engberg et al. 2004; 
Kassenborg et al. 2004), and there is evidence to support a substantial prevalence of FQ-resistant 
Campylobacter in poultry meat products (Endtz et al. 1991). However, foreign travel and swimming 
have also been identified as important risk factors (Engberg et al. 2004). The level of resistance 
appears to be related to the frequency of use of FQ (Padungton and Kaneene 2003). Thus, resistance 
to FQ among bacteria is higher in areas such as the Mediterranean (Baquero 1996) where FQ use is 
relatively high. Conversely, levels of FQ usage and of resistance amongst Campylobacter spp. in 
Scandinavian countries are typically low (Anon 2005a; Bengtsson et al. 2005). In Scandinavia, 
quinolone-resistant Campylobacter infections are often acquired by people during foreign travel 
(Sjogren et al. 1992; Norstrom et al. 2006) and in the UK and Scandinavia consignments of imported 
poultry meat have been identified as sources (Gaunt and Piddock 1996; Anon 2005a) 
E. coli is a ubiquitous gut commensal organism with zoonotic potential but concerns in this 
regard have focused on verotoxigenic E. coli O157, for which antimicrobial therapy is usually 
contraindicated, and to a lesser extent on other toxigenic strains. There is, however, much evidence 
suggesting that E. coli strains which are primarily classed as commensals in farm livestock may 
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colonise the human intestinal tract (Linton 1977; Achtman et al. 1986; Cherifi et al. 1991, 1994) and 
human infection by antibiotic-resistant E. coli can be acquired by contact with farm animals (Levy et 
al. 1976; Linton 1977; Nijsten et al. 1994; Aarestrup and Wegener 1999). Further spread of these 
organisms within local communities has also been demonstrated (reviewed by Aarestrup and 
Wegener 1999). E. coli from animals found as contaminants on food can also colonise man (Cooke 
et al. 1970; Linton 1986).  
FQ resistance in human E. coli isolates from blood and cerebrospinal fluid has been increasing 
in the UK since 1991 (Threlfall et al. 1998). Furthermore, E. coli FQ resistance appears to be 
especially marked in parts of the world with fewer constraints on the use of antimicrobials, such as 
some Mediterranean countries and the Middle East (Amara et al. 1995; Al-Mustafa and Al-Ghamdi 
2000). However, the transfer of FQ resistance from veterinary strains of E. coli in contaminated food 
to human strains in the intestinal tract is assumed to be a low risk, as quinolone resistance is 
considered typically to be carried on the bacterial chromosome rather than on plasmids (Zhang et al. 
2003), and experimental work in chickens (van Boven et al. 2003) has shown a lower propensity for 
selection of FQ resistance for E. coli than for Campylobacter jejuni. This may change in future as a 
human isolate of E. coli possessing a conjugative plasmid encoding a qnr determinant conferring low 
level resistance to quinolones has been reported for the first time in Europe (Mammeri et al. 2005). 
The majority of antimicrobial products sold for use in food animals in the UK are authorised 
for pigs and poultry (http://www.vmd.gov.uk/Publications/Antibiotic/AntiPubs.htm) and bacteria in 
such systems might therefore be expected to exhibit relatively high levels of resistance to the 
antibiotics used including fluoroquinolones. The nature of the breeding pyramids and short 
production cycles mean that, depending on the mode(s) of the transfer of resistance, the impact of FQ 
resistance could spread rapidly through commercial units. In view of the foregoing, the present study 
examined pig and poultry units for FQ resistance, focusing on Campylobacter and E. coli. The latter 
bacterium was chosen both in view of its zoonotic potential and, being a ubiquitous representative of 
the Enterobacteriaceae, as an indicator species particularly for Salmonella. The irregular occurrence 
and clonal distribution of salmonellas independent of antimicrobial usage makes representative 
studies of Salmonella more difficult to perform. In the present studies, the prevalence of FQ 
resistance was examined at the farm level, and data were collected concurrently for risk factor 
analyses, which will be reported elsewhere. 
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MATERIALS AND METHODS 
Recruitment for the surveys 
Poultry. The target population for the survey was defined as: ‘poultry meat (broiler and turkey) farms 
in England and Wales with at least 1,000 birds on site’. This population, of 960 holdings, accounted 
for 99.9% of poultry meat (broiler and turkey) birds according to the MAFF June census of England 
and Wales in 1999. Most of the study population was recruited by approaching the relatively small 
number of large integrated poultry companies in England and Wales. Companies associated with 224 
sites (23% of the estimated 960 large poultry sites in England and Wales), two of which were turkey 
companies, agreed to take part in the survey. Participating companies supplied complete lists of their 
poultry sites, which were used as sampling frames from which approximately one third of each 
company’s sites were randomly chosen for inclusion. To ensure representation of independent 
growers, additional recruitment was done by advertising in a trade magazine. All eligible 
independent growers that responded were included in the survey.  
Pigs. The target population was defined as: ‘pig finishing (breeding to finishing, or growing and 
finishing) farms in England, Scotland and Wales, with at least 100 breeding females if breeder to 
finish, or 200 finisher places if specialist finishers’. There were 2,650 eligible holdings in Great 
Britain according to the June 2002 Agricultural Census. Four hundred and sixteen pig farms, selected 
at random from lists provided by Quality Meat Scotland (QMS), Assured British Pigs and the 
National Pig Association, were contacted by their organisations and invited to join the study.  
 
Organisation of field work and sampling protocols. 
Poultry survey work was carried out between June 2001 and June 2003. Sampling and data collection 
on farms was done by either company-appointed poultry veterinarians or poultry company staff 
under the supervision of the company veterinarian. The independent poultry producers carried out 
the sampling and data collection themselves. Pig survey work was carried out between December 
2002 and October 2003. Sampling and data collection on pig farms was carried out by the farm 
manager and the farm’s private veterinarian. 
A protocol for sampling was devised, to provide a sensitivity of about 95% for the detection of 
resistant bacteria being shed on a unit. Assuming a minimum prevalence of 5% of animals on an 
affected farm shedding resistant bacteria and also assuming 90% sensitivity of the laboratory 
detection method, calculations based on binomial probabilities showed that 95% sensitivity could be 
achieved by taking samples from 64 animals into eight pools. 
On each poultry farm, 64 separate fresh floor droppings were picked up from the litter from 
random locations in up to four houses. The samples were pooled into eight pots, each containing 
eight droppings samples. On pig farms, to meet the requirements of concurrent research projects, up 
to 30 faeces sample pools were created in pots. Each pot contained mixed faeces from at least eight 
animals. Eight pots were randomly selected for use in the present study. Sampling was targeted on 
birds or pigs near to slaughter, therefore houses containing the oldest birds, and only pens containing 
finishing pigs were chosen for sampling. Each pot was stirred with a fresh transport medium swab 
for the preservation of Campylobacter. The pots and swabs were transported to the laboratory by 
post. Background data on the farm, including FQ use, were collected using questionnaires completed 
by the farm manager and/or the attending veterinarian. 
 
Laboratory processing of the samples 
For isolation of E. coli, 1 g of faeces from each pool was mixed with 9 ml buffered peptone water 
(BPW; Oxoid), and 100 μl aliquots of each suspension were spread over the surface of chromogenic 
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E. coli / coliform agar plates (Chromagar ECC; CM956, Oxoid) containing 1.0 mg l-1 ciprofloxacin, 
and incubated overnight at 37oC. Plates streaked with control E. coli were incubated under the same 
conditions. Controls comprised one strain sensitive to ciprofloxacin, NCTC 10418 (National 
Collection of Type Cultures, Colindale, London, UK), and three strains from the VLA culture 
archive with known minimum inhibitory concentrations of 0.5 mg l-1 (F3), 1.0 mg l-1 (F15) and 
2.0 mg l-1 (F13). The BPW suspensions were also incubated at 37oC overnight. If the primary culture 
plates produced no growth, Chromagar ECC plates with ciprofloxacin were then inoculated with the 
pre-enriched sample in BPW and incubated overnight. 
For isolation of thermophilic Campylobacter spp., transport swabs inoculated with pooled 
faeces (eight swabs per unit) were first streaked onto 10% (v v-1) sheep blood agar plates containing 
Skirrow’s antibiotic supplement (vancomycin, 10 mg l-1; polymyxin B, 2500 iu l-1; trimethoprim, 
5 mg l-1; actidione, 250 mg l-1) and cefoperazone 15 mg l-1 (BASAC) to which 1.0 mg l-1 
ciprofloxacin had been added, for primary culture. Control plates were streaked with one strain of C. 
jejuni sensitive to ciprofloxacin, NCTC 81116 (National Collection of Type Cultures, Colindale, 
London, UK), and one ciprofloxacin-resistant strain from the VLA culture archive (VLA 00/051). 
All the swabs from each unit were then pooled in 10 ml Exeter broth [Bolton broth (27.6 g l-1, 
CM983 Oxoid Ltd, Basingstoke, UK), Campylobacter growth supplement (sodium metabisulphate, 
sodium pyruvate and ferrous sulphate, all at 250 mg  -1; SV61 Mast diagnostics, Bootle, UK), 
Campylobacter selective supplement (trimethoprim, 10 mg l-1; rifampin, 5 mg l-1, polymyxin B, 
2500 iu l-1; cefoperazone, 15 mg l-1; amphotericin B, 2 mg l-1; SV59 Mast Diagnostics) and 
defibrinated horse blood (10 ml l-1; TCS Biosciences Ltd, Botolph Claydon, UK)]. The BASAC and 
Exeter broth were incubated for 48 h at 37oC in a microaerophilic (6% O2, 10% CO2) incubator 
(Heraeus). After 48 h incubation, 50 µl aliquots of the inoculated Exeter media were streaked onto 
each of a BASAC plus ciprofloxacin (1.0 mg l-1) and a plain BASAC plate, which were incubated for 
24 to 48 h microaerophilically at 37oC. 
The growth of colonies typical of E. coli or Campylobacter on media containing ciprofloxacin 
(1.0 mg l-1), where growths of ciprofloxacin- sensitive and ciprofloxacin-resistant control strains on 
the media were as expected, was taken to indicate that FQ-resistant bacteria were present in the 
faeces in the pot and therefore the farm of origin was classed as ‘affected’. The identity of putative E. 
coli colonies was confirmed using standard o-nitrophenyl-beta-galactopyranoside and indole tests 
with inconclusive results checked by API 20E (bioMérieux (UK) Ltd, Basingstoke, Hampshire). 
Colonies showing morphology typical of Campylobacter on BASAC were identified using standard 
oxidase, catalase, indoxyl acetate (CAMP 1A Kit; Mast Diagnostics) and hippurate tests. 
Representative E. coli isolates from each positive sample were stored on Dorset egg slopes and used 
in further investigations. Campylobacter spp. isolated from BASAC with and without ciprofloxacin 
were stored in 10% glycerol broth at minus 80oC for comparative typing investigations. 
 
Estimation of relative proportions of resistant bacteria 
E. coli. Aliquots (100 μl) of serial dilutions of faeces pools in phosphate-buffered saline were spread-
plated onto paired Chromagar ECC plates with and without 1.0 mg l-1 ciprofloxacin and colonies 
typical of E. coli were counted after overnight incubation. 
Campylobacter. Aliquots (100 μl ) of pooled faeces of positive samples from 5 pig farms which had 
been serially diluted in Exeter broth and incubated microaerophilically for 48 h at 42oC were spread-
plated onto BASAC plates, with and without 1.0 mg l-1 ciprofloxacin, and Campylobacter colonies 
counted following incubation at 42oC under microaerophilic conditions for 48 h. 
The proportions of the E. coli and Campylobacter populations that were resistant were calculated by 
comparison of colony counts on ciprofloxacin and non-ciprofloxacin plates. 
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Minimum inhibitory concentration (MIC) of ciprofloxacin 
Using the ciprofloxacin-resistant E. coli recovered from farms, as described above, MIC values to 
ciprofloxacin were determined by an agar doubling dilution method similar to that of the Clinical and 
Laboratory Standards Institute (NCCLS, 1997), with the main difference being that iso-sensitest agar 
(CM471 Oxoid Ltd) rather than Mueller Hinton agar was used. The reference strains for quality 
control were E. coli ATCC 25922 (NCCLS, 1997) and three strains from the VLA culture archive 
with known minimum inhibitory concentrations of 0.5 mg l-1 (F3), 1.0 mg l-1 (F15) and 2.0 mg l-1 
(F13). Briefly, bacteria grown overnight at 37oC in BPW were diluted 1/100 in peptone water and 
inoculated, using a multi-point inoculator, onto the agar with suitable dilutions of ciprofloxacin. 
Plates were incubated overnight at 37oC and the MIC was recorded as the lowest concentration of 
ciprofloxacin inhibiting growth. 
A selection of 24 and 33 ciprofloxacin-resistant Campylobacter isolates recovered from pigs 
and poultry respectively were evaluated by the NCCLS agar dilution method as described by Randall 
et al (2003). Briefly, the inoculum was prepared by growing the strains for 48 h on BASAC. Growth 
was emulsified in saline to a density approximating to McFarland No. 0.5 turbidity standard and used 
to inoculate Mueller Hinton agar (CM337 Oxoid Ltd) plates supplemented with 5% haemolysed 
horse blood and standardised concentrations of ciprofloxacin, using a multi-point inoculator. 
Inoculated plates were incubated at 37oC in a variable atmosphere incubator (VAIN; Don Whitley 
Scientific) at H2 3%, CO2 5%, O2 5%, N2 87% for 48 h with the humidity adjusted to 50%. The MIC 
was taken as the concentration of ciprofloxacin that caused inhibition of growth by more than 90%. 
Control strains comprised Campylobacter fetus subsp. fetus NCTC 10842, C. jejuni NCTC 11168, C. 
NCTC 11351, Campylobacter lari NCTC 11352 and Campylobacter coli NCTC 11366. 
 
Statistical analysis 
To account for over-representation of certain strata within the poultry sample, weighting factors were 
used in the estimation of prevalence of affected farms in the target population. Weighting factors 
were not used in the analysis of pig data, as the study population closely matched the target 
population in respect of geographic distribution and representation of breeder versus grower units. 
Ninety five percent confidence intervals (CI95) for the national prevalences of affected units were 
calculated using EpiInfo version 6 (Centers for Disease Control and Prevention U.S.A. & World 
Health Organisation, Geneva, Switzerland). 
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RESULTS 
Participating farms 
A total of 89 poultry farms were sampled and included in the analysis. The sample contained distinct 
strata, depending on type of ownership and type of end product. Independent growers and turkey 
farms accounted for 22% and 24% of the farms sampled respectively. These sectors were both over-
represented, as the MAFF June census of England and Wales in 1999 gave figures of 10% for 
independents and 17% for turkey farms. The use of FQ (past and/or present) was reported on 25% of 
poultry farms. 
Amongst pig units, the final sample used in the analysis was of 108 farms. The population of 
sampled farms generally matched the geographical distribution of the national herd. The only major 
stratification of farm type was breeder/finisher versus grower/finisher. Breeding farms made up 55% 
of the sample, compared with 59% of eligible GB holdings which had breeding pigs (June 2002 
Agricultural Census). The use of FQ (past and/or present) was reported on 66% of pig farms. 
Correlation between FQ resistance and use of these antimicrobials on farms will be reported 
elsewhere as part of a detailed risk factor analysis. 
 
Prevalence of affected farms 
The sample prevalences of farms where FQ-resistant organisms were detected, and the estimates of 
the prevalence in the target population (weighted in the case of poultry) with exact binomial CI95 are 
shown for Campylobacter (Table 1) and E. coli (Table 2). 
Enrichment was required to grow FQ-resistant E. coli from samples from 37% (23 of 63) of the 
pig farms where resistant E. coli were detected, but from only 6% (3 of 53) of similarly affected 
poultry farms. In contrast, enrichment was required to grow FQ-resistant Campylobacter from 
samples from only 4% (3 of 81) pig farms where resistant Campylobacter was detected, but from 
30% (6 of 20) of similarly affected poultry farms. 
The distributions of resistant organisms isolated from farms are summarised in Fig. 1. 
Resistance in both bacterial species was common amongst pigs (52% of farms) and turkeys (38% of 
farms), but much less common in broilers (7% of farms). More pig farms had resistance in 
Campylobacter than in E. coli, and most with resistant E. coli also had resistant Campylobacter. 
Conversely, more poultry farms had resistance in E. coli than in Campylobacter. All of the turkey 
farms with resistant Campylobacter also had resistant E. coli. 
 
Proportions of resistant bacteria 
Bacterial population assessments for FQ-resistant versus total E. coli were carried out on 23 pooled 
faeces samples from each of eight poultry and seven pig farms affected by FQ resistance (Fig. 2). A 
wide range of proportions of FQ-resistant E. coli was found, with ranges of 0.00045% to 37% for 
poultry, and 0.0079% to 53% for pigs. 
From five pig farms, 19 samples containing FQ-resistant Campylobacter were examined to 
estimate the proportion of resistant Campylobacter cells in the population. These proportions fell 
within a wide range, both within and between farms, of <10% to 100%. Estimations of resistant 
Campylobacter proportions were not carried out on any poultry samples. 
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Minimum inhibitory concentrations of ciprofloxacin 
Of the 235 resistant E. coli tested, 226 were resistant to ciprofloxacin at concentrations >8 mg l-1, and 
the remainder at 2 to 4 mg l-1. For Campylobacter spp., all 33 isolates from poultry recovered on 
1 mg l-1 ciprofloxacin media and susceptibility tested had MIC values to ciprofloxacin of ≥8 mg l-1 
(range 8-128). Three of 24 pig isolates from 1 mg l-1 ciprofloxacin media examined had MIC values 
of 2 mg l-1, three had an MIC of 4 mg l-1 and the rest had MIC values of ≥8 mg l-1. All control strains 
gave the anticipated results. 
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DISCUSSION 
The primary aim of the present survey was to estimate the proportion of poultry and pig farms 
in the target populations that were affected by FQ-resistant bacteria. The precision of this estimate is 
determined solely by the number of farms in the sample. The percentages of ‘affected’ farms 
presented in tables 1 and 2 have CI95 of about +/- 10%, with the exception of the estimates for the 
turkey farm stratum alone, which are +/- 20%. The accuracy of the estimated affected proportion of 
farms in the target population is influenced by the sensitivity and specificity of the detection method, 
and by any bias in the sample. 
A low sensitivity of detection would lead to under-estimation. Several factors can affect 
sensitivity, in particular the on-farm sampling strategy, the effect of transit conditions on the samples 
and the sensitivity of the laboratory method. The sampling strategy was designed to give a 95% 
probability (i.e. sensitivity) of retrieving resistant bacteria on an affected farm, provided that a 
minimum of 5% of animals were shedding such bacteria. The effects of transit conditions on the 
samples are likely to have been variable, depending on the species of bacteria, and various sample 
transit factors such as time and temperature. Because Campylobacter is generally thought to be less 
robust than E. coli, detection sensitivity may have been lower for the former. For this reason, 
transport swabs were used for portions of the pools subjected to culturing for Campylobacter. 
When devising the cultural methods, the primary concern was for sensitive detection of 
‘affected’ farms (i.e. to minimise false negative results). The classical methods of plating on non-
selective media followed by sub-culturing and testing of a ‘sub-sample’ of colonies for FQ 
resistance, or of replica plating, may not have been sufficiently sensitive. It was decided, therefore, to 
use antibiotic-supplemented media in the primary isolation plates. Enrichment was performed in 
parallel, to maximise the probability of recovery from samples with low concentrations of viable 
target bacteria. Ciprofloxacin at 1 mg l-1 was used in all plates as it was considered that stressed 
organisms plated onto an inhibitory selective medium (BASAC) containing a higher level of 
ciprofloxacin may result in reduced growth of resistant organisms, increasing the likelihood of false 
negative results. MIC values were then determined for a selection of potentially resistant isolates to 
establish their level of resistance. 
The finding that the proportion of the tested E. coli population resistant to FQ could be as low 
as approximately 5 in 106 indicates the value of using the isolation approach described here. With 
such low numbers of resistant organisms, it is unlikely that they would have been detected by non-
selective primary isolation and subsequent sub-culture. In addition to direct plating, enrichment of 
samples prior to plating helped to improve detection of low numbers of resistant organisms, 
particularly for Campylobacter spp. where six of the 18 positive poultry farms were detected only 
following enrichment of the pooled sample. A large majority of E. coli (96%) and Campylobacter 
(89%) isolates that were tested following isolation on ciprofloxacin-containing media had MIC 
values greater than 8 mg l-1. Thus, the methods are considered to have been successful in identifying 
fully-resistant organisms, even when present in low numbers amongst a background of non-resistant 
members of the same species. Therefore the current results do not necessarily represent a sudden 
increase in the prevalence of affected farms compared with that reported previously; the higher 
prevalences reported here are more likely due to the detection method employed being more 
sensitive to a low prevalence of resistant organisms than are conventional sub-culturing or replica 
plating approaches. 
A potential risk with highly sensitive detection methods is a lack of specificity. This would 
result in the incorrect classification of farms as ‘affected’ (false positive results) with a consequent 
over-estimation of the proportion affected. The use of ciprofloxacin in primary isolation plates 
reduced the work required to identify resistant organisms and improved the sensitivity of the 
detection method over the classical two-stage approach. However, the inclusion of 1 mg l-1 
ciprofloxacin in culture media potentially could select resistant bacteria spontaneously mutating in 
 11
situ at the normal background frequency or developing phenotypic resistance due to induction of 
efflux pumping (Ge et al. 2005; Yan et al. 2006), rather than identifying pre-existing resistant clones. 
However, control E. coli strains with ciprofloxacin MIC values of 0.5 mg l-1 and <0.016 mg l-1 were 
plated 144 times during the course of the survey work. On no occasion did these controls grow on 
test plates containing 1.0 mg l-1 ciprofloxacin. Similarly, repeated inoculation of ciprofloxacin plates 
with FQ-sensitive control campylobacters during the study did not yield any growth of spontaneous 
mutants. 
This low potential for producing false positive results with the culture techniques used is 
supported by a theoretical model estimating the probabilities of growing FQ-resistant E. coli from a 
non-resistant source. Based on assumptions of a potential mutation rate of 1 in 107 E. coli and one 
resistant mutant per 106 colony forming units (cfu), modelling suggested a very low likelihood of 
growing 20 or more spontaneously resistant colonies on more than one plate inoculated with up to 
107 cfu. An inoculum of non-resistant E. coli of the order of 102-105 cfu for pig and 104-107 cfu for 
poultry faeces was determined from the enumeration studies. All poultry farms and all but six pig 
farms classified as affected for FQ-resistant E. coli produced more than 20 colonies on more than 
one plate. Furthermore, the mutation rate assumption used is rather generous, as measured rates for 
E. coli have been in the range of one per 109 to 1011 in the face of media containing 2 to 16x the MIC 
of a FQ (Kern et al. 2000), so even with enriched inocula the theoretical possibility of selecting 
spontaneous mutants occurring after sampling is low. 
MIC values of ≥2 mg l-1 ciprofloxacin among E. coli typically are seen after two or more 
stages of selection in vitro (Kern et al. 2000), and it is possible that the detection method employed 
in the present study would have selected second-stage resistant E. coli, with multiple mutations in 
topoisomerase and efflux genes, from a background of first-stage mutants with low-level FQ 
resistance of debatable significance. However, the mutation rate to second-stage resistance has been 
shown to be of the order of one per 108 first-stage mutants plated (Kern et al. 2000) and therefore, 
similar to the discussion above, it remains highly unlikely that the observed results are a consequence 
of this and not of the pre-existence on the premises of resistance at clinically-significant MIC levels. 
Considering Campylobacter, single-stage mutation to grow on media containing ciprofloxacin 
at 1-2 mg l-1 has been reported to occur in C. jejuni at a rate of around 1 per 108 cells plated (Gootz 
and Martin 1991) and more recently at a rate of between 7 per 103 and 4 per 109 cells plated 
(Hanninen and Hannula 2007). Under normal circumstances, measured concentrations of 
Campylobacter in pig caecal contents and broiler faeces are around 104 to 106 cfu g-1 (Harvey et al., 
2001; Stern and Robach 2003). Therefore, even with inocula of 1 g faeces per plate, i.e. significantly 
more than the swab inoculation used in the present study, very few plates (probably fewer than one 
in 100) would have grown a spontaneously ciprofloxacin-resistant Campylobacter sp. unless the 
mutation rate was consistently at the highest end of the ranges quoted. In fact, the 91% of positive 
farms that did not require enrichment for detection yielded resistant Campylobacter from a median of 
three (of eight) plates. Furthermore, where enrichment was performed for farms negative on direct 
culture, 90% of these farms still proved negative for resistant Campylobacter. The above 
considerations indicate that the incidental detection of post-sampling spontaneous FQ-resistant 
Campylobacter mutants was very likely to have been of negligible significance in the present work. 
The accuracy of the estimate for the proportion of ‘affected’ farms in the target population is 
affected by the correlation between the sample and the population from which it is drawn. If the 
sample is in some ways biased compared to the target population (e.g. for farm types) the sample 
proportion may not be an accurate indicator of the population proportion. In Tables 1 and 2, 
adjustments to the results were made to account for over-representation of turkey farms and 
independent broiler farms in the poultry sample. This should allow more accurate inferences to be 
made about the wider population of poultry farms. However, such inferences must also assume that 
there were no significant biases between the poultry companies that were included and those that 
were not. Differences in the proportion of farms with resistant bacteria were seen between the 
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companies included in the survey (data not shown) and so it is not possible to assume that the 
companies included and those not included in the survey were highly similar. Therefore, inferences 
about the prevalence of shedding of FQ-resistant organisms in the general population of poultry 
farms should be treated with caution. However, animals were shedding resistant bacteria on a high 
proportion of farms and, in view of the wide confidence intervals (+/- approximately 10%), it seems 
reasonable to assume that the situation in other companies does not differ so greatly that the 
prevalence of affected farms in the population as a whole is much outside these confidence limits. 
 
With regard to the relevance of the results to public health, the present survey detected FQ-
resistant E. coli and Campylobacter in animal faeces from high proportions of farms although there 
were differences, both between farmed species and between bacterial species. There was a 
significantly lower level of resistance in Campylobacter amongst poultry compared with pigs, which 
may reflect a higher innate tendency of C. coli , the predominant pig species, to acquire resistance 
compared with C. jejuni, which predominates amongst poultry (Gupta et al. 2004; Boes et al. 2005). 
The prevalence of resistant E. coli was significantly higher than that of resistant Campylobacter on 
poultry farms, particularly for broilers. This may reflect seasonal and age-related variation in 
prevalence observed for Campylobacter and/or differences in carry-over of resistant Campylobacter 
spp. and E. coli between batches and in the farm environment following cleaning and disinfection. 
The consumption of livestock food products is believed to be a risk factor for humans 
acquiring a FQ-resistant Campylobacter infection, and a recent red meat abattoir survey performed in 
Great Britain (Veterinary Laboratories Agency, unpublished data) suggested that 2% of C. jejuni and 
11% of C. coli recovered from rectal or caecal contents of cattle, sheep and pigs were resistant to 
ciprofloxacin using the England and Wales Health Protection Agency breakpoint of 1 mg l-1. 
However, the majority of FQ-resistant Campylobacter spp. were isolated from pigs, with no resistant 
isolates recovered from sheep. Results of genotyping and phenotyping suggest that pig strains have 
significantly lower overlap with human-derived campylobacters than do poultry-derived strains 
(Kramer et al. 2000; Guevremont et al. 2004; Siemer et al. 2005). 
The situation in respect of poultry appears subject to significant geographical variation. The 
prevalence of FQ resistance is high in the Netherlands, with surveillance from 2004 indicating 
resistance in 40.4% of C. jejuni isolates (Anon 2005b). In France, the prevalence of resistance 
appears to have fallen in recent years (Gallay et al. 2007) and FQ resistance in C. jejuni from broilers 
in Scandinavia and Northern Ireland is generally around or below 5% of isolates (Oza et al. 2003; 
Bengtsson et al. 2005; Norstrom et al. 2006). Therefore, whilst in some areas poultry should be 
considered as a significant risk for human consumption of FQ-resistant Campylobacter, other 
important factors should not be overlooked. Indeed, foreign travel is consistently reported as the 
most important risk factor for human infections with an FQ-resistant Campylobacter in Scandinavia 
(Osterlund et al. 2003; Engberg et al. 2004; Norstrom et al. 2006). Another possible risk is 
acquisition from domestic pets (Moore et al. 2002). 
The detection methods used in the present study were designed to maximise sensitivity, and a 
substantial proportion of farms were subsequently classified as ‘affected’. However, the proportion 
of animals that were excreting resistant bacteria on farm or at slaughter is unknown. The probability 
that consumers are exposed to FQ-resistant bacteria through contamination of carcases is highly 
dependent upon this latter proportion and upon further factors, including the fraction of the bacterial 
population that is resistant (for E. coli in the current study, often less than 1%), and the degree of gut 
spillage, cross-contamination and organism survival in the food processing and retail chain. Further 
epidemiological studies, linked to risk modelling, would be required to assess fully the potential risk 
to public health posed by FQ-resistant E. coli and Campylobacter of food animal origin. 
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Table 1 Prevalence, with 95% confidence intervals (CI95), of farms where fluoroquinolone-
resistant Campylobacter spp. were detected 
 
Farm type 
Total farms 
sampled 
Farms with FQ-resistance 
Number % 
Weighted 
estimate (%) 
Lower 
CI95* (%) 
Upper 
CI95* (%) 
Broiler   68 12 17.6 19.4 11 31 
Turkey   21   8 38.1 41.5 22 66 
All poultry   89 20 22.5 23.4 15 34 
       
Pig 108 81 75.0 75.0 66 83 
 
 
 
Table 2 Prevalence, with 95% confidence intervals (CI95), of farms where fluoroquinolone-
resistant E. coli were detected 
 
Farm type 
Total farms 
sampled 
Farms with FQ-resistance 
Number % 
Weighted 
estimate (%) 
Lower 
CI95* (%) 
Upper 
CI95* (%) 
Broiler   68 34 50.0 45.4 33 58 
Turkey   21 19 90.5 91.0 70 99 
All poultry   89 53 59.6 53.1 42 63 
       
Pig 108 63 58.3 58.3 48 68 
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Figure 1 Distribution of resistant organisms isolated from farms 
Resistance patterns:  no resistance;  E. coli only resistant; 
 Campylobacter only resistant;  both E. coli and Campylobacter resistant 
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Figure 2 Proportion of fluoroquinolone-resistant E. coli in 23 individual sample pools, each 
containing resistant E. coli, from eight poultry ( ) and seven pig (  ) farms 
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